The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies last night and win an international competition for best project by an organization.
Sloan-Kettering won the Franz Edelman Award for Achievement in Operations Research for work entitled "Operations Research Answers to Cancer Therapeutics." The work improves the survival rate of patients with prostate cancer, reduces the side effects of treatment, and reduces costs to the health care system.
Yesterday was the first time that the association awarded the Edelman prize for a medical treatment. The Sloan-Kettering win demonstrates how operations research and mathematics are increasingly bringing improvements to health care, not only in the areas of policy, finance, and public health but in diagnosis and treatment, as well.
Dr. Marco Zaider, Attending Physicist in Medical Physics at Memorial Sloan-Kettering Cancer Center received the award together with Professor Eva K. Lee, Director of the Center for Operations Research in Medicine and HealthCare in the School of Industrial and Systems Engineering at Georgia Institute of Technology.
The 2007 Franz Edelman Award winner was announced at a special awards banquet during The Institute for Operations Research and the Management Sciences (INFORMS) Conference on O.R. Practice in Vancouver. http://meetings.informs.org/Practice07/ The finalists included Coca-Cola Enterprises, Hewlett-Packard, DaimlerChrysler, and the U.S. Coast Guard.
Dr. Lee and Dr. Zaider devised sophisticated optimization modeling and computational techniques to implement an intra-operative 3D treatment planning system for brachytherapy (the placement of radioactive "seeds" inside a tumor) that offers a safer and more reliable treatment.
The real-time intra-operative planning system eli
Contact: Barry List
Institute for Operations Research and the Management Sciences